Public Health Foundation of India, Gurgaon, Haryana, India.
Public Health Foundation of India, Gurgaon, Haryana, India.
Vaccine. 2018 Jun 18;36(26):3836-3841. doi: 10.1016/j.vaccine.2018.05.006.
The costs of delivering routine immunization services in India vary widely across facilities, districts and states. Understanding the factors influencing this cost variation could help predict future immunization costs and suggest approaches for improving the efficiency of service provision. We examined determinants of facility cost for immunization services based on a nationally representative sample of sub-centres and primary health centres (99 and 89 facilities, respectively) by regressing logged total facility costs, both including and excluding vaccine cost, against several explanatory variables. We used a multi-level regression model to account for the multi-stage sampling design, including state- and district-levelrandom effects. We found that facility costs were significantly associated with total doses administered, type of facility, salary of the main vaccinator, number of immunization sessions, and the distance of the facility from the nearest cold chain point. Use of pentavalent vaccine by the state was an important determinant of total facility cost including vaccine cost. India is introducing several new vaccines including some supported by Gavi. Therefore, the government will have to ensure that additional resources will be made available after the support from Gavi ceases.
在印度,提供常规免疫服务的成本在各设施、地区和邦之间差异很大。了解影响这种成本差异的因素可以帮助预测未来的免疫成本,并提出提高服务提供效率的方法。我们根据全国代表性的次级中心和初级保健中心(分别为 99 和 89 个设施)的样本,对免疫服务设施成本的决定因素进行了检查,方法是将包括和不包括疫苗成本的对数总设施成本与几个解释变量进行回归。我们使用多水平回归模型来解释包括州和地区层面的随机效应的多阶段抽样设计。我们发现,设施成本与管理的总剂量、设施类型、主要接种员的工资、免疫接种次数以及设施与最近冷链点的距离显著相关。州使用五联疫苗是包括疫苗成本在内的总设施成本的一个重要决定因素。印度正在引进几种新疫苗,包括一些得到全球疫苗免疫联盟支持的疫苗。因此,政府必须确保在全球疫苗免疫联盟的支持结束后,提供额外的资源。